Gyre Therapeutics
GYRE
GYRE
56 hedge funds and large institutions have $23.8M invested in Gyre Therapeutics in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.04% more ownership
Funds ownership: 3.47% → 3.51% (+0.04%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $14K
Holders
56
Holding in Top 10
–
Calls
–
Puts
$14K
Top Buyers
| 1 | +$326K | |
| 2 | +$298K | |
| 3 | +$112K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$110K |
| 5 |
BHCM
Brevan Howard Capital Management
St. Helier,
Jersey
|
+$107K |
Top Sellers
| 1 | -$356K | |
| 2 | -$175K | |
| 3 | -$126K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$67K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$55.6K |
